129 related articles for article (PubMed ID: 11107061)
1. Molecular mechanism of monocyte predominant infiltration in chronic inflammation: mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer.
Yamamoto T
Pathol Int; 2000 Nov; 50(11):863-71. PubMed ID: 11107061
[TBL] [Abstract][Full Text] [Related]
2. Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor.
Shrestha A; Shiokawa M; Nishimura T; Nishiura H; Tanaka Y; Nishino N; Shibuya Y; Yamamoto T
Am J Pathol; 2003 Apr; 162(4):1381-8. PubMed ID: 12651630
[TBL] [Abstract][Full Text] [Related]
3. S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a.
Nishiura H; Shibuya Y; Yamamoto T
Lab Invest; 1998 Dec; 78(12):1615-23. PubMed ID: 9881961
[TBL] [Abstract][Full Text] [Related]
4. Roles of the ribosomal protein S19 dimer and the C5a receptor in pathophysiological functions of phagocytic leukocytes.
Yamamoto T
Pathol Int; 2007 Jan; 57(1):1-11. PubMed ID: 17199736
[TBL] [Abstract][Full Text] [Related]
5. [A novel monocyte chemotactic factor that connects innate immunity and acquired immunity].
Yamamoto T
Rinsho Byori; 2000 Jul; 48(7):634-8. PubMed ID: 11051789
[TBL] [Abstract][Full Text] [Related]
6. Agonistic and antagonistic effects of C5a-chimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively.
Oda Y; Tokita K; Ota Y; Li Y; Taniguchi K; Nishino N; Takagi K; Yamamoto T; Nishiura H
J Biochem; 2008 Sep; 144(3):371-81. PubMed ID: 18515853
[TBL] [Abstract][Full Text] [Related]
7. Guinea pig S19 ribosomal protein as precursor of C5a receptor-directed monocyte-selective leukocyte chemotactic factor.
Umeda Y; Shibuya Y; Semba U; Tokita K; Nishino N; Yamamoto T
Inflamm Res; 2004 Nov; 53(11):623-30. PubMed ID: 15693611
[TBL] [Abstract][Full Text] [Related]
8. Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection.
Shrestha A; Horino K; Nishiura H; Yamamoto T
Lab Invest; 1999 Dec; 79(12):1629-42. PubMed ID: 10616212
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion.
Shi L; Tsurusaki S; Futa N; Sakamoto T; Matsuda T; Nishino N; Kunitomo R; Kawasuji M; Tokita K; Yamamoto T
Virchows Arch; 2005 Oct; 447(4):747-55. PubMed ID: 16012852
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer.
Nishimura T; Horino K; Nishiura H; Shibuya Y; Hiraoka T; Tanase S; Yamamoto T
J Biochem; 2001 Mar; 129(3):445-54. PubMed ID: 11226885
[TBL] [Abstract][Full Text] [Related]
11. Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.
Shibuya Y; Shiokawa M; Nishiura H; Nishimura T; Nishino N; Okabe H; Takagi K; Yamamoto T
Am J Pathol; 2001 Dec; 159(6):2293-301. PubMed ID: 11733378
[TBL] [Abstract][Full Text] [Related]
12. Agonist and antagonist dual effect of the cross-linked S19 ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes.
Revollo I; Nishiura H; Shibuya Y; Oda Y; Nishino N; Yamamoto T
Inflamm Res; 2005 Feb; 54(2):82-90. PubMed ID: 15750715
[TBL] [Abstract][Full Text] [Related]
13. The role of the ribosomal protein S19 C-terminus in altering the chemotaxis of leucocytes by causing functional differences in the C5a receptor response.
Nishiura H; Zhao R; Yamamoto T
J Biochem; 2011 Sep; 150(3):271-7. PubMed ID: 21613290
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein.
Nishiura H; Shibuya Y; Matsubara S; Tanase S; Kambara T; Yamamoto T
J Biol Chem; 1996 Jan; 271(2):878-82. PubMed ID: 8557699
[TBL] [Abstract][Full Text] [Related]
15. The roles of a ribosomal protein S19 polymer in a mouse model of carrageenan-induced acute pleurisy.
Yamanegi K; Kawakami T; Yamada N; Kumanishi S; Futani H; Nakasho K; Nishiura H
Immunobiology; 2017 May; 222(5):738-750. PubMed ID: 28190533
[TBL] [Abstract][Full Text] [Related]
16. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
[TBL] [Abstract][Full Text] [Related]
17. Base of molecular mimicry between human ribosomal protein S19 dimer and human C5a anaphylatoxin.
Nishiura H; Chen J; Ota Y; Semba U; Higuchi H; Nakashima T; Yamamoto T
Int Immunopharmacol; 2010 Dec; 10(12):1541-7. PubMed ID: 20869475
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms to form leukocyte infiltration patterns distinct between synovial tissue and fluid of rheumatoid arthritis.
Yamamoto T; Nishiura H; Nishida H
Semin Thromb Hemost; 1996; 22(6):507-11. PubMed ID: 9122716
[TBL] [Abstract][Full Text] [Related]
19. A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells.
Horino K; Nishiura H; Ohsako T; Shibuya Y; Hiraoka T; Kitamura N; Yamamoto T
Lab Invest; 1998 May; 78(5):603-17. PubMed ID: 9605185
[TBL] [Abstract][Full Text] [Related]
20. A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation.
Semba U; Chen J; Ota Y; Jia N; Arima H; Nishiura H; Yamamoto T
Am J Pathol; 2010 Mar; 176(3):1542-51. PubMed ID: 20093496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
